- Home
- TRDA vs RNAC Comparison
TRDA vs RNAC Comparison
Compare TRDA & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- RNAC
- Stock Information
- Founded
- TRDA 2016
- RNAC 2007
- Country
- TRDA United States
- RNAC United States
- Employees
- TRDA N/A
- RNAC N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- TRDA Health Care
- RNAC Health Care
- Exchange
- TRDA Nasdaq
- RNAC Nasdaq
- Market Cap
- TRDA 233.5M
- RNAC 276.3M
- IPO Year
- TRDA 2021
- RNAC 2016
- Fundamental
- Price
- TRDA $5.33
- RNAC $9.92
- Analyst Decision
- TRDA Strong Buy
- RNAC Strong Buy
- Analyst Count
- TRDA 3
- RNAC 4
- Target Price
- TRDA $25.67
- RNAC $40.00
- AVG Volume (30 Days)
- TRDA 223.5K
- RNAC 49.2K
- Earning Date
- TRDA 11-04-2025
- RNAC 11-06-2025
- Dividend Yield
- TRDA N/A
- RNAC N/A
- EPS Growth
- TRDA N/A
- RNAC N/A
- EPS
- TRDA N/A
- RNAC N/A
- Revenue
- TRDA $79,476,000.00
- RNAC $1,026,000.00
- Revenue This Year
- TRDA N/A
- RNAC N/A
- Revenue Next Year
- TRDA N/A
- RNAC N/A
- P/E Ratio
- TRDA N/A
- RNAC N/A
- Revenue Growth
- TRDA N/A
- RNAC N/A
- 52 Week Low
- TRDA $4.93
- RNAC $8.46
- 52 Week High
- TRDA $21.79
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- TRDA 44.26
- RNAC 39.94
- Support Level
- TRDA $5.08
- RNAC $9.73
- Resistance Level
- TRDA $5.39
- RNAC $10.83
- Average True Range (ATR)
- TRDA 0.25
- RNAC 0.51
- MACD
- TRDA 0.02
- RNAC -0.02
- Stochastic Oscillator
- TRDA 24.53
- RNAC 21.25
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.